Search results for virus

“DARPA's research is part of the Pandemic Prevention Program, or P3. Their goal is to determine which monoclonal antibodies the body produces when it encounters a particular virus, such as SARS-CoV-2, and then stimulate the body's production of those antibodies.”

“Immunity and susceptibility to COVID-19 is an area of ongoing research. Findings from a recent study indicate that T cells that react to the SARS-CoV-2 spike protein are present in both COVID-19 patients and healthy people unexposed to the virus.”

“SARS-CoV-2 is the virus responsible for COVID-19. As SARS-CoV-2 infection rates climb, scientists continue to search for drugs that could be repurposed for COVID-19 treatment. Authors of a new multiomics study report that melatonin use dramatically reduced the likelihood of SARS-CoV-2 infection, especially for African Americans.”

“Previous research has demonstrated that transplanting the microbiota of patients with depression into germ-free mice can induce depressive symptoms in these animals. The study involved 311 participants between the ages of 18 and 65 years, roughly half of whom had been diagnosed with major depressive disorder.”

“The researchers found that the Moderna vaccine was between 81 and 91 percent effective and the Pfizer-BioNTech vaccine was between 69 and 81 percent effective against infection with the original SARS-CoV-2 virus prior to May 2021.”

“Following infection with the SARS-CoV-2 infection, the adaptive immune system produces neutralizing antibodies that attack the virus and prevent further illness in those who recover. Vaccination provides another means of developing long-lasting immunity.”

“Scientists have identified an emerging pattern of associations between SARS-CoV-2 (the virus that causes COVID-19) and Parkinson's disease. For example, the loss of smell is one of the most common symptoms reported in SARS-CoV-2 infection, but it is also an early symptom of Parkinson's disease, often preceding diagnosis by many years.”

“Symptoms of COVID-19 range from mild upper airway distress to progressive life-threatening viral pneumonia. At the time of this writing, more than 22 million people have been infected with the virus and more than 782,000 people have died.”

“Cases of new-onset diabetes, hyperglycemia, and diabetic ketoacidosis (a life-threatening condition that can accompany hyperglycemia) in people who have had COVID-19 are on the rise. The SARS-CoV-2 virus exploits the ACE2 receptor to gain entry into cells and replicate.”

“The delta variant of SARS-CoV-2, the virus that causes COVID-19, exhibits greater resistance to antibodies and higher transmissibility than other variants, raising concerns that people who have been vaccinated might be vulnerable to breakthrough infections and subsequent complications.”